Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
Syder AJ, Lee H, Zeisel MB, Grove J, Soulier E, Macdonald J, Chow S, Chang J, Baumert TF, McKeating JA, McKelvy J, Wong-Staal F.
Syder AJ, et al. Among authors: lee h.
J Hepatol. 2011 Jan;54(1):48-55. doi: 10.1016/j.jhep.2010.06.024. Epub 2010 Aug 21.
J Hepatol. 2011.
PMID: 20932595